Register

CAR-T: The evolution of a revolution?

Thursday, 3 October 2019 | 16.00-18.30 | Kursaal C

Organised by Novartis

Do CAR-T – Chimeric antigen receptor T-cell – therapies have the potential to revolutionise cancer care? These therapies are disrupting traditional concepts of immuno-oncology, manufacturing, delivery and value across Europe. However, for many, there remain a number of open questions that need to be addressed.

Join Novartis in a series of critical conversations with both early adopters and advocates who will highlight the transformative potential of these therapies, and sceptical voices who will focus on the unknown variables and where current challenges lie.

The session will detail the science, safety, efficacy and value of CAR-T as well as the evolution of cell and gene therapies over the past 20 years. Delegates will hear from key thought leaders and patient representatives about the impact of CAR-T can have on healthcare systems, pricing, and regulation. Join us and be part of this exciting and complex debate on opportunities and challenges presented by CAR-T for all stakeholders!

Photo Gallery
Webcast

Speakers & Panellists

INPUT FROM

ANTONIA MÜLLER, Senior Consultant, Division of Hematology, University Hospital Zurich

EMANUELE OSTUNI, Head of Cell and Gene Therapy, Oncology Region Europe, Novartis

MARIUS GEANTA, President, Centre for Innovation in Medicine (InoMed), Romania

ŠARUNAS NARBUTAS, President, Lithuanian Cancer Patient Coalition (POLA)

THOMAS SZUCS, Professor of Pharmaceutical Medicine, University of Basel

ZACK PEMBERTON-WHITELEY, Patient Advocacy Director, Acute Leukaemia Advocates Network

ANTONELLA CARDONE, Director, European Cancer Patient Coalition

MODERATOR

Duane Schulthess, Managing Director, Vital Transformation

Available Biographical Information

Name
CV
Abstract
Presentation
NameMuller, Antonia
CVDownload PDF
NameOstuni, Emanuele
CVDownload PDF
NameGeanta, Marius
CVDownload PDF
NameNarbutas, Šarunas
CVDownload PDF
NameSzucs, Thomas
CVDownload PDF
NamePemberton-Whiteley, Zack
CVDownload PDF
NameCardone, Antonella
CVDownload PDF
NameSchulthess, Duane
CVDownload PDF

Organisers

EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
BIC SBGSAT2S
Bank Salzburger Sparkasse
Kirchplatz, 5630 Bad Hofgastein, Austria